Literature DB >> 21800948

Evidence-based risk assessment and recommendations for physical activity: arthritis, osteoporosis, and low back pain.

Philip D Chilibeck1, Hassanali Vatanparast, Stephen M Cornish, Saman Abeysekara, Sarah Charlesworth.   

Abstract

We systematically reviewed the safety of physical activity (PA) for people with arthritis, osteoporosis, and low back pain. We searched PubMed, MEDLINE, Sport Discus, and the Cochrane Central Register of Controlled Trials (1966 through March 2008) for relevant articles on PA and adverse events. A total of 111 articles met our inclusion criteria. The incidence for adverse events during PA was 3.4%-11% (0.06%-2.4% serious adverse events) and included increased joint pain, fracture, and back pain for those with arthritis, osteoporosis, and low back pain, respectively. Recommendations were based on the Appraisal of Guidelines for Research and Evaluation, which applies Levels of Evidence based on type of study ranging from high-quality randomized controlled trials (Level 1) to anecdotal evidence (Level 4) and Grades from A (strong) to C (weak). Our main recommendations are that (i) arthritic patients with highly progressed forms of disease should avoid heavy load-bearing activities, but should participate in non-weight-bearing activities (Level 2, Grade A); and (ii) patients with osteoporosis should avoid trunk flexion (Level 2, Grade A) and powerful twisting of the trunk (Level 3, Grade C); (iii) patients with acute low back pain can safely do preference-based PA (i.e., PA that does not induce pain), including low back extension and flexion (Level 2, Grade B); (iv) arthritic patients with stable disease without progressive joint damage and patients with stable osteoporosis or low back pain can safely perform a variety of progressive aerobic or resistance-training PAs (Level 2, Grades A and B). Overall, the adverse event incidence from reviewed studies was low. PA can safely be done by most individuals with musculoskeletal conditions.

Entities:  

Mesh:

Year:  2011        PMID: 21800948     DOI: 10.1139/h11-037

Source DB:  PubMed          Journal:  Appl Physiol Nutr Metab        ISSN: 1715-5312            Impact factor:   2.665


  7 in total

1.  Arthritis, osteoporosis, and low back pain: evidence-based clinical risk assessment for physical activity and exercise clearance.

Authors:  Jamie Burr; Roy Shephard; Stephen Cornish; Hassanali Vatanparast; Philip Chilibeck
Journal:  Can Fam Physician       Date:  2012-01       Impact factor: 3.275

Review 2.  Qualified exercise professionals: best practice for work with clinical populations.

Authors:  Darren E R Warburton; Sarah A Charlesworth; Heather J A Foulds; Donald C McKenzie; Roy J Shephard; Shannon S D Bredin
Journal:  Can Fam Physician       Date:  2013-07       Impact factor: 3.275

3.  Neuromuscular Adaptations to Low-Load Blood Flow Restricted Resistance Training.

Authors:  Summer B Cook; Brendan R Scott; Katherine L Hayes; Bethany G Murphy
Journal:  J Sports Sci Med       Date:  2018-03-01       Impact factor: 2.988

Review 4.  High-intensity versus low-intensity physical activity or exercise in people with hip or knee osteoarthritis.

Authors:  Jean-Philippe Regnaux; Marie-Martine Lefevre-Colau; Ludovic Trinquart; Christelle Nguyen; Isabelle Boutron; Lucie Brosseau; Philippe Ravaud
Journal:  Cochrane Database Syst Rev       Date:  2015-10-29

5.  Using Postmarket Surveillance to Assess Safety-Related Events in a Digital Rehabilitation App (Kaia App): Observational Study.

Authors:  Deeptee Jain; Kevin Norman; Zachary Werner; Bar Makovoz; Turner Baker; Stephan Huber
Journal:  JMIR Hum Factors       Date:  2021-11-09

Review 6.  [Formalized consensus: clinical practice recommendations for the management of acute low back pain of the African patient].

Authors:  Mohamed Elleuch; Abdellah El Maghraoui; Brahim Griene; Mati Nejmi; Souhaibou Ndongo; Alain Serrie
Journal:  Pan Afr Med J       Date:  2015-11-13

7.  Changes in physical activity and risk of fracture: a Korean nationwide population-based cohort study.

Authors:  Sangsoo Han; Hae-Dong Jang; Sungwoo Choi; Gi Deok Kim; Kyungdo Han; Hyunwoong Lim; Bongmo Koo; Kyung Dae Min; Jae-Young Hong
Journal:  Sci Rep       Date:  2020-10-01       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.